EichorEICHOR
Location: Yonago Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Yonago

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Tottori University Hospital · Eli Lilly and Company · NCT06890598A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Tottori University Hospital · Turning Point Therapeutics, Inc. · NCT03093116A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
Phase 3 · Ep0156 802 · UCB Biopharma SRL · NCT04715646A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurre
Phase 3 · Tottori University Hospital · Rakuten Medical, Inc. · NCT06699212A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Tottori University Hospital · Eli Lilly and Company · NCT06119581MSA-01 in Multiple System Atrophy
Phase 3 · Tottori University Hospital · Tokyo University · NCT07446894A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
Phase 3 · Tottori University Hospital · argenx · NCT07596849A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · Tottori University Hospital · Bayer · NCT06452277Isolated Surgical Aortic Valve Replacement in Low Risk AS Patients
NA · Tottori University · Osaka University · NCT06924151Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）
Phase 3 · Tottori University Hospital · Kyowa Kirin Co., Ltd. · NCT06926491A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Phase N/A · Tottori University Hospital · BioMarin Pharmaceutical · NCT06212947Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Phase N/A · Investigational Site Number : 153203 · Genzyme, a Sanofi Company · NCT00358943Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Phase 3 · Tottori University Hospital · Summit Therapeutics · NCT05899608First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations i
Phase 1/Phase 2 · Tottori University Hospital · Bayer · NCT05099172
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.